Random forest approach to predict genes correlated with adaptive responses to KRASG12C inhibitor
PLOS One · 11.11.2026 · 21 (11) · e0359938
DOI: 10.1371/journal.pone.0359938 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 11.11.2026. Verfasst von Gregory P Riddick und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, School of Medicine, Virginia Commonwealth University, Richmond, Virginia, United States of America. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins p21(ras), Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Drug Resistance, Neoplasm. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
KRAS mutations represent one of the most common and clinically challenging oncogenic drivers in non–small cell lung cancer (NSCLC), a leading cause of cancer mortality. The recent development of KRAS inhibitors, particularly targeting KRAS G12C has transformed the therapeutic landscape. However, despite these advances, treatment benefits remain limited as most patients experience disease progression within months due to adaptive or acquired resistance mechanisms. The incomplete understanding of the adaptive and acquired resistance mechanisms restricts our progression toward the development of effective therapeutic intervention. Particularly, we questioned whether common, targetable molecular vulnerabilities exist across distinct KRAS G12C tumor contexts during the early adaptive window under therapeutic pressure, preceding the establishment of overt drug resistance. To address this, we employed a Random Forest to single-cell RNA sequencing data from three KRAS G12C mutant NSCLC cell lines, enabling systematic ranking of genes associated with proliferative versus quiescent cell-state annotations. Our analysis recapitulated established proliferation-associated genes at baseline and revealed distinct gene signatures emerging at 72 hours of treatment, enriched for translational control and other biological pathways. Notably, PHF19 and TMEM106C were consistently prioritized across cell lines and showed higher direct expression in the proliferating populations, supporting their designation as candidate correlates of the residual proliferative state during early adaptation. These findings define proliferation and differentiation as a potential early vulnerability in KRAS G12C mutant NSCLC and provide a conceptual framework for intercepting resistance development, requiring subsequent external and functional validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, School of Medicine, Virginia Commonwealth University, Richmond, Virginia, United States of America.
- Medical Scientist Training Program, School of Medicine, Virginia Commonwealth University, Richmond, Virginia, United States of America.
- Massey Comprehensive Cancer Center, Virginia Commonwealth University, Richmond, Virginia, United States of America.
- Department of Cell, Molecular, and Genetic Medicine, School of Medicine, Virginia Commonwealth University, Richmond, Virginia, United States of America.
- Research Institute of Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America.
- Department of Cancer and Cellular Biology, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, United States of America.
ORCID-Profile: Allison Pittman, Hyeong-Min Lee
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- National Cancer Institute
- Fox Chase Cancer Center
- VCU Massey Cancer Center
- NIGMS
Zitieren
APA
Riddick, G. P., Pittman, A., McHale, S. S., Parajuli, P., Zhu, B., Scoyk, M. V., Wu, P. Y., Chou, C. F., Lee, H. M., & Winn, R. A. (2026). Random forest approach to predict genes correlated with adaptive responses to KRASG12C inhibitor. PLOS One, 21(11), e0359938. https://doi.org/10.1371/journal.pone.0359938
Vancouver
Riddick GP, Pittman A, McHale SS, Parajuli P, Zhu B, Scoyk MV, et al. Random forest approach to predict genes correlated with adaptive responses to KRASG12C inhibitor. PLOS One. 2026;21(11):e0359938. doi:10.1371/journal.pone.0359938
BibTeX
@article{Riddick2026,
author = {Riddick, Gregory P and Pittman, Allison and McHale, Stephanie S and Parajuli, Parash and Zhu, Bin and Scoyk, Michelle Van and Wu, Pei-Ying and Chou, Chu-Fang and Lee, Hyeong-Min and Winn, Robert A},
title = {Random forest approach to predict genes correlated with adaptive responses to KRASG12C inhibitor},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {11},
pages = {e0359938},
doi = {10.1371/journal.pone.0359938}
}
EUVIMED